Cargando…
Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis
Interleukin-33 (IL-33), a member of the IL-1 superfamily, functions as a traditional cytokine and nuclear factor. It is proposed to have an “alarmin” role. IL-33 mediates biological effects by interacting with the ST2 receptor and IL-1 receptor accessory protein, particularly in innate immune cells...
Autores principales: | Li, Liya, Zhu, Honglin, Zuo, Xiaoxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249369/ https://www.ncbi.nlm.nih.gov/pubmed/30498500 http://dx.doi.org/10.3389/fimmu.2018.02663 |
Ejemplares similares
-
Therapeutic Opportunities of Interleukin-33 in the Central Nervous System
por: Sun, Yun, et al.
Publicado: (2021) -
Pathogenesis of Systemic Sclerosis
por: Pattanaik, Debendra, et al.
Publicado: (2015) -
Interleukin-33 in Malignancies: Friends or Foes?
por: Shen, Jia-Xin, et al.
Publicado: (2018) -
The role of platelets in the pathogenesis of systemic sclerosis
por: Ramirez, Giuseppe A., et al.
Publicado: (2012) -
Role of Interleukin-33 in Staphylococcus epidermidis-Induced Septicemia
por: Yang, Min, et al.
Publicado: (2020)